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Context: Serum thyroid hormone levels differ between children and adults, but have not been
studied longitudinally through childhood.
Objective: To assess changes in thyroid-stimulating hormone (TSH) and thyroid hormone levels over
childhood and their interrelationships.
Design: Cohort study.
Setting: The Avon Longitudinal Study of Parents and Children, a population-based birth cohort.
Participants:A total of 4442 childrenwhohad thyroid functionmeasured at age 7, and 1263 children
who had thyroid function measured at age 15. Eight hundred eighty-four children had mea-
surements at both ages.
Main Outcome Measures: Reference ranges for TSH, free tri-iodothyronine (FT3), free thyroxine
(FT4), their longitudinal stability, and interrelationships.
Results: Children at age 7 years had a higher FT3 [6.17 pmol/L, standard deviation (SD) 0.62] than
children at age 15 (5.83 pmol/L, SD 0.74); P, 0.0001with 23.2%of children at age 7having FT3 above
the adult reference range. Higher FT3 levels at age 7 in boys (P = 0.0001) and girls (P = 0.04) were
associated with attainment of a more advanced pubertal stage at age 13. TSH was positively
associated with FT3 at age 7 and age 15 even after adjusting for confounders. In contrast, TSH was
negatively associated with FT4.
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Conclusions: There are substantial changes in TSH and thyroid hormone levels over childhood, in
particular for FT3, which appear to relate to pubertal readiness. Our data provide increased insight
into the evolution of the pituitary–thyroid axis over childhood and may have implications for
determining optimal ranges for thyroid hormone replacement in children. (J Clin Endocrinol Metab
102: 2508–2515, 2017)
Thyroid hormones play an important role in devel-opmental processes, including growth, maintenance
of metabolic balance, and cell development (1). Even
minor variation in thyroid hormone status within the
normal population reference range is associated with
important phenotypic consequences (2). The complex
inverse relationship between thyroid-stimulating hor-
mone (TSH) and free thyroxine (FT4) renders TSH the
more sensitive marker of overall thyroid status (3). Free
tri-iodothyronine (FT3) is the active thyroid hormone,
although serum levels only indirectly reflect overall
thyroid status because a substantial proportion of intra-
cellular FT3 is produced from conversion of intracellular
FT4 by deiodinases (4, 5). However, there is some evidence
that T3 may have a more important role than previously
assumed in both the assessment and therapy of thyroid
disease in younger children (6).
Thyroid hormone levels are largely genetically de-
termined (7), with similar effects from genetic variation
observed in children and adults (8). Although it is well
established in adults that there is narrow intraindividual
variation in thyroid hormone parameters compared with
interindividual variation (9), increased variance and
ranges in thyroid hormone levels have been observed
throughout childhood, and adult reference intervals may
not be universally applicable to children (10–12). Pre-
vious cross-sectional studies have indicated that FT3
substantially falls and FT4 rises from age 4 (13–15), but
there have been no longitudinal studies to confirm these
observations. Furthermore, from genetic analyses we
have recently identified that higher body mass index and
adiposity appear to causally increase FT3, but not TSH or
FT4 levels (16); therefore, the longitudinal stability of
thyroid hormones over childhood, and FT3 in particular,
remains unclear.
In this report, we studied TSH and thyroid hormone
levels at ages 7 and 15 in a large population birth cohort.
We assessed age and sex reference ranges in 4442 healthy
children at age 7 and 1253 children at age 15 (884
children had thyroid function measured at both time
points). We also explored the longitudinal variability of
TSH and thyroid hormone levels using linear mixed
models by sex, pubertal status, and body mass index
(BMI) and also assessed the relationship between TSH
and thyroid hormone at different time points over
childhood.
Methods
Participants
Avon Longitudinal Study of Parents andChildren (ALSPAC)
is a prospective birth cohort that enrolled .13,000 pregnant
women in the former County of Avon, UK, with an expected
delivery date between April 1991 and December 1992 (17, 18)
(see www.alspac.bris.ac.uk). Children were regularly brought
back to focus clinics where data were collected and phenotypic
measurements and blood sampleswere taken. The studywebsite
contains details of all the data that are available through a fully
searchable database: www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary/. Ethical approval for the study was
obtained from the ALSPAC Ethics and Law Committee and the
Local Research Ethics Committees. There were no children on
levothyroxine or antithyroid medications in the study dataset.
Laboratory measures
TSH, FT3, and FT4 were measured during 2010–2011 on
remaining frozen stored serum samples taken from the focus at
age 7 years (median age 89 months) and focus at age 15 clinics
(median age 184 months). Samples were analyzed using
chemiluminescent emission utilizing a photomultiplier on cobas
e601 (Roche Diagnostics, Mannheim, Germany). A total of
4442 samples was available for full thyroid function testing at
age 7 years, and 1253 were available at age 15 years. A total of
884 children samples was available and processed at both ages 7
and 15. Reference ranges for adults are TSH, 0.27 to 4.2 mU/L;
FT3, 3.9 to 6.7 pmol/L; and FT4, 12 to 22 pmol/L. It has been
previously demonstrated that TSH and FT4 can be analyzed
reliably in samples stored for up to 23 years (19). The intra-
assay precision coefficients of variance for TSH, FT3, and FT4
were ,3.1%, ,4%, and ,4%, respectively. The interassay
precision coefficients of variance were ,7.3%, ,6%, and
,7%, respectively.
Phenotypic measures
Standing height was measured using a wall-mounted Har-
penden stadiometer (Holtain, Crymych, UK). BMI was calcu-
lated as weight (in kilograms) divided by height (in meters)
squared. Pubertal status was self-assessed using a Tanner stage
questionnaire at age 13.5 years (pubic hair domain), range 13.1
to 14.4 years.
Statistical analysis
Implausible TSH and thyroid hormone levels [.4 standard
deviation (SD) from the mean for the sex- and age-specific
category] were considered as outliers and were recoded to
missing. TSHwas loge transformed to an approximately normal
distribution. Descriptive statistics are presented as geometric
means, SD, median, and 95th centiles.
A linear mixed model with random intercepts and random
slopes was used to assess the trends of TSH and thyroid
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hormone parameters over childhood (20). An unstructured
variance–covariance matrix was assumed. We analyzed the
baseline values at age 7, the variability at baseline, the longi-
tudinal trend (slope) between ages 7 and 15, and the variability
in the slope. Analyses were performed with gender interactions
and gender X puberty interactions. Model simplification was
undertaken using likelihood ratio tests. Additional analysis was
undertaken adjusting for BMI, as this may be associated with
pubertal development and FT3 in particular or on the causal
pathway between thyroid status and pubertal development.
We then explored the relationship between TSH and thyroid
hormone levels at ages 7 and 15. Here thyroid function was
standardized, and therefore results are presented as per SD
change in the outcome. Analyses were initially performed ad-
justed for age at thyroid measurements and gender (model 1).
Three further models controlling for key potential confounders
were undertaken; model 2 also adjusted for thyroid hormone
parameters, model 3 also adjusted for measures of social class
and early life environment including parents’ home ownership,
maternal age at birth of child, maternal highest educational
qualification, maternal smoking in pregnancy, family adversity
index, and parents and home score. Likelihood ratio tests were
used to identify whether there was any evidence of interaction
by sex on the relationship between thyroid hormone parameters
and TSH.
Results
Study population and baseline characteristics
The derivation of study participant numbers is shown
in Fig. 1. A total of 80 children at age 7 (1.8%) and 38
children at age 15 (2.9%) met the outlier exclusion.
Children in our final analysis dataset were more likely to
have several higher markers of affluence and fewer early
life events than the remainder of the ALSPAC cohort
(Supplemental Table 1).
Serum thyroid hormone levels in
children at ages 7 and 15
At age 7 years, the mean and 95%
reference range values for TSH, FT3,
and FT4 were 2.26 (0.93 to 4.48) mU/L,
6.29 (5.13 to 7.59) pmol/L, and 15.7
(12.7 to 19.3) pmol/L, respectively
(Table 1). A total of 23.2% of children
at age 7 years had a FT3 above the adult
reference range, with only 3.65% of
children having a TSH and 0.2% of
children having FT4 values above the
adult reference range (Fig. 2; Table 1).
At age 15 years, the mean and 95%
reference range values for TSH, FT3,
and FT4 were 2.43 (0.91 to 5.05) mU/L,
5.83 (4.45 to 7.35) pmol/L, and 15.5
(11.9 to 20.3) pmol/L, respectively
(Fig. 3; Table 1), with a marked re-
duction in children having FT3 above
the adult reference range to 12.2%, which was mainly in
girls (Table 1). Analysis of just the 884 children who had
thyroid function at both ages 7 and 15 revealed similar
results (Supplemental Table 2). There was a modest cor-
relation between TSH levels between ages 7 and 15
(Pearson’s correlation coefficient = 0.35), which was
similar for FT4 (Pearson’s correlation coefficient = 0.33),
although amuchweaker correlation was observed for FT3
(Pearson’s correlation coefficient = 0.10). Bland–Altman
plots revealed no evidence of heteroskedasticity for TSH,
FT3, and FT4 (Supplemental Fig. 1).
Linear mixed models analysis in children with
thyroid function at age 7 and age 15
TSH levels rose between ages 7 and 15 years, whereas
both FT3 and FT4 levels fell. Strong negative correlations
were observed in the models for TSH FT3 and FT4, in-
dicating that those with higher levels at age 7 years were
more likely to have more substantial lowering of levels at
age 15, and those with lower levels at age 7 were likely to
have smaller reductions at age 15, i.e., a convergence of
biomarkers (Table 2). Every 2 years between ages 7 and
15 years, TSH levels increased by 0.03 mU/L [95%
confidence interval (CI) 0.02, 0.05], P , 0.001. Boys
had a higher baseline TSH than girls at age 7 years by
0.11mU/L (95%CI 0.06, 0.17), P, 0.001. There was no
difference in mean gain between boys and girls between
ages 7 and 15 years, B = 0.0001 (95%CI20.001, 0.001),
P = 0.83, and no difference in variability at base-
line 20.04 (95% CI 20.10, 0.03), P = 0.29, or in the
variability of the slope B = 5.73 3 10206 (95%
CI 20.0002 and 0.0003), P = 0.65 (Table 2).
Figure 1. Study participants.
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For FT3, every 2 years between the ages of 7 and
15 years, FT3 levels fell 0.12 pmol/L (95% CI 20.13,
20.10). Girls had a higher baseline FT3 level than boys by
0.13 pmol/L (95% CI 0.09, 0.17), P , 0.001. However,
boys had a reduced decline in FT3 than girls, B = 0.008
(95% CI 0.007, 0.009), P , 0.001. There was no sub-
stantial difference by sex in variability at baseline B = 0.02
(95% CI 20.01, 0.05), P = 0.29, or in variability in slope
B = 7.85310206 (95%CI25.18310206, 2.01310205),
P = 0.24 (Table 2). Every 2 years, FT4 levels fell 0.04 pmol/
L (95% CI 20.07, 20.01), P = 0.005. Girls had a higher
baseline FT4 level than boys by 0.38 pmol/L (95%CI 0.28,
0.48), P, 0.001, and also hadmore variability at baseline
at age 7 years, B = 0.38 (95% CI 0.14, 0.62), P = 0.002,
although there was no difference in variability in slope
B = 4.47 3 10205 (95% CI 4.47 3 10205, 0.001), P =
0.33 (Table 2). Adjusting the analysis for BMI revealed
similar results, although it markedly attenuated the
slope for TSH (Supplemental Table 3).
Relationship between pubertal status at age 13 and
TSH and thyroid hormone parameters at ages 7
and 15
A total of 2702 children also had pubertal status self-
assessed at age 13 years as well as having thyroid function
measured. As expected, girls had a higher Tanner score
than boys 3.63 (95% CI 3.58, 3.69) vs 2.96 (95% CI
2.89, 3.02), P , 0.0001. Pubertal status at age 13 years
was not associated with TSH levels at age 7 in boys (P =
0.89) or girls (P = 0.31). No difference in TSH slope by
pubertal status was observed in boys (P = 0.82) or girls
(P = 0.82). Pubertal status at age 13 years was also not
associated with FT4 levels at age 7 years in boys (P = 0.32)
or girls (P = 0.52). By contrast, FT3 levels at age 7 years
were higher in both boys (P = 0.0001) and girls (P = 0.04)
with more advanced puberty at age 13 years (Table 3).
More advanced pubertal status at age 13 years was,
however, associated with a negative FT3 slope unlike
children at an earlier pubertal status at age 13, which
had a positive FT3 slope, in both boys and girls (P #
0.001). Similarly, there was no evidence of any difference
in the variability of baseline values or gradients of slopes
by pubertal status in either boys or girls for either FT3 or
FT4. Although BMI at age 7 was also associated with
Tanner stage at age 13, B = 0.08 (95%CI 0.06, 0.09), P,
0.001, and FT3, B = 0.04 (95%CI 0.03, 0.05), P, 0.001,
adjusting for BMI at age 7 had no substantial effect on the
relationship between FT3 and Tanner stage. Analysis of
the association between FT3 and Tanner stage when
adjusted for sex was B = 0.12 (95% CI 0.07, 0.12), P ,
0.001; adding BMI to the model had aminimal impact on
effect estimates, B = 0.10 (95%CI 0.05, 0.15), P, 0.001.
Furthermore, adjustment for BMI in the linear mixed
models performed by pubertal status revealed very
similar results to our original analysis (Supplemental
Table 4).
Table 1. Reference Range for Thyroid Hormone Parameters Age 7 and Age 15
All Males Females
Age (Y) N Mean
(2.5%–
97.5%)
%
Above
ARR
%
Below
ARR N Mean
(2.5%–
97.5%)
%
Above
ARR
%
Below
ARR N Mean
(2.5%–
97.5%)
%
Above
ARR
%
Below
ARR
TSH (mU/L) 4442 2.26 0.93–4.48 3.65 0 2323 2.32 0.97–4.50 3.57 0 2119 2.20 0.88–4.45 3.73 0
FT3 (pmol/L) 7 4442 6.29 5.13–7.59 23.2 0.09 2323 6.23 5.07–7.56 19.8 0.17 2119 6.35 5.16–7.59 26.9 0
FT4 (pmol/L) 4422 15.7 12.7–19.3 0.20 0.70 2323 15.6 12.7–19.0 0.17 0.73 2119 15.9 12.85–19.55 0.24 0.66
TSH (mU/L) 1263 2.43 0.91–5.05 6.33 0 644 2.51 0.91–5.17 7.92 0 619 2.34 0.87–5.00 4.68 0
FT3 (pmol/L) 15 1263 5.83 4.45–7.35 12.2 0.55 644 6.16 4.84–7.6 20.7 0 619 5.48 4.23–6.91 3.39 1.13
FT4 (pmol/L) 1263 15.5 11.9–20.3 0.79 2.69 644 15.5 11.8–20.2 0.62 2.95 619 15.5 12.0–20.6 0.97 2.42
Abbreviation: ARR, adult reference range.
Figure 2. (a) Histogram of TSH levels at age 7 (vertical lines refer to adult reference range). (b) Histogram of FT3 levels at age 7 (vertical lines
refer to adult reference range). (c) Histogram of FT4 levels at age 7 (vertical lines refer to adult reference range).
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Relationship between TSH and serum thyroid
hormone levels in children at ages 7 and 15 years
At age 7 years, TSH was weakly positively associated
with FT3 after adjusting for age, sex, FT4, and markers of
social class and early life environment, B standardized
(std) = 0.03 (95%CI 0.001, 0.06), P = 0.05, whereas TSH
was clearly negatively associatedwith FT4, B (std) =20.07
(95%CI20.10,20.04), P = 3.493 10205 (Supplemental
Table 5). A similar pattern was also observed at age
15 years even after adjusting for pubertal status, with TSH
positively associated with FT3, B (std) = 0.07 (95% CI
0.02, 0.13), P = 0.01, and negatively associated with
FT4, B (std) = 20.13 (95% CI 20.19, 20.07), P =
5.163 10206 (Supplemental Table 5). FT3 and FT4 were
positively associated with each other at age 7 years, B
(std) = 0.27 (95% CI 0.24, 0.30), P = 1.123 10214, and
also at age 15 years, B = 0.19 (95% CI 0.12, 0.26), P =
4.233 10207. Seemingly unrelated regression identified
that the positive impact of TSH on FT3 was greater at
age 15 years than at age 7 years (P = 0.001), but no
difference was observed with FT4 (P = 0.84).
Discussion
Our results from a longitudinal analysis of a large
population birth cohort demonstrate that there are
substantial changes in the pituitary–thyroid axis over
childhood. In particular, FT3 changes much more over
childhood than either TSH or FT4. Levels of FT3 at age 7
are high compared with adult values, with almost 25% of
children at age 7 years having a FT3 level above the adult
reference range. Although there is a substantial fall in FT3
levels between age 7 years and age 15 years, 10% are still
above the adult reference range.
There was a very strong negative correlation between
hormone levels between ages 7 and 15, indicating that the
substantial variability observed in early childhood is
reduced through puberty, with hormone levels con-
verging to near adult reference values. Overall, our data
suggest that there may be higher conversion of FT4 to FT3
in younger children than adults. Our observation that
boys maintain a higher FT3 for longer than girls is also
noteworthy, and may have substantial importance in
observed sex differences in bone development (21) and
other phenotypes (2).
The reason that children have higher FT3 levels at age 7
years is unclear but may be due to factors external to the
pituitary–thyroid axis, such as fat mass and pubertal
development (16). In the current study, we noted that
children that reached puberty earlier (as indicated by
more advanced self-reported pubertal stage at age 13 years)
had higher FT3 values at age 7 years and a negative FT3
slope between ages 7 and 15 years, whereas those with less
advanced puberty had a positive FT3 slope between ages 7
and 15 years. Using both serum thyroid function and then
genetic data to perform Mendelian Randomization, we
have recently reported that BMI and fat mass in children
are positively and causally related to FT3 (16). Although the
effect of FT3 on puberty is interestingly largely in-
dependent of BMI, it is, however, still possible that FT3
is an indicator of nutritional state and hence pubertal
readiness in early childhood in a manner similar to leptin.
Alternatively, the observed changesmay represent changes
in the thyroid gland in preparation for puberty, or be a
consequence of changes in other endocrine factors such
as growth hormone, as growth hormone therapy has
been linked to marginally increased FT3 and decreased
FT4 levels (22).
We have also identified a difference in the relationship
between TSH and the two thyroid hormones FT3 and FT4
in childhood, with higher TSH being associated with
higher FT3, whereas an inverse association was identified
with FT4. The positive association between TSH and FT3
in childhood has been highlighted recently in children
with borderline thyroid status (23). This observation
provides insight into childhood TSH-FT4 and TSH-FT3
relationships that are relevant to our understanding of
both thyroid physiology and the laboratory diagnosis of
thyroid disease. It is interesting to speculate the life course
of FT3 levels given it is well established that FT3 in
particular declines in the elderly (24); the pattern of FT3
through life may therefore be a fall over childhood (25),
Figure 3. (a) Histogram of TSH levels at age 15 (vertical lines refer to adult reference range). (b) Histogram of FT3 levels at age 15 (vertical lines
refer to adult reference range). (c) Histogram of FT4 levels at age 15 (vertical lines refer to adult reference range).
2512 Taylor et al Thyroid Function Over Childhood J Clin Endocrinol Metab, July 2017, 102(7):2508–2515
then plateauing throughout adult life, before falling again
in older age.
We believe our findings are also clinically relevant, given
the striking differences observed in early childhood thyroid
hormone levels from adult-derived reference ranges. If age-
and sex-appropriate reference ranges are not used, there
may be substantial overdiagnosis of subclinical thyroid
disease in children. In addition, our finding that children
have substantially higher FT3 levels than adults may have
implications for thyroid hormone replacement in children.
Individuals on levothyroxine have a higher FT4 and a lower
FT3 than euthyroid individuals despite having similar TSH
levels (26–28). Children on levothyroxine might therefore
have inadequate FT3 levels for optimal timing of puberty
and other developmental processes. It is noteworthy that
hypothyroidism diagnosed in prepubertal years can cause a
delay of puberty (29). It is also possible that the relative lack
of FT3 in these children may potentially be one of the
reasons that optimal IQ levels are not reached in children
with congenital hypothyroidism despite adequate levo-
thyroxine therapy (30). Taken together, there remains a
pressing need for further study of central and peripheral
determinants of thyroid function aswell as determinants of
intracellular thyroid status in children.
Strengths of our dataset include the use of a large
population birth cohort with detailed phenotypic data
Table 2. Overall Linear Mixed Models for TSH FT3 and FT4
Parameter Group Measure Factor Coefficient 95% CI P Value
TSH (mU/L) All Main effects Age 7 years 2.27 (2.24, 2.3) ,0.001
Slope 0.0013 (0.0007, 0.002) ,0.001
Variability SD@ Age 7 years 1.62 (1.56, 1.67)
SD Slope 0.14 (0.13, 0.14)
Correlation (int, slope) 20.87 (20.89, 20.86)
FT3 (pmol/L) All Main effects Age 7 years 6.29 (6.27, 6.31) ,0.001
Slope 20.005 (20.005, 20.004) ,0.001
Variability SD@ Age 7 years 1.28 (1.24, 1.32)
SDSlope 0.12 (0.11, 0.12)
Correlation(int, slope) 20.92 (20.93, 20.91)
FT4 (pmol/L) All Main effects Age 7 years 15.7 (15.7, 15.8) ,0.001
Slope 20.002 (20.03, 20.0005) 0.005
Variability SD@ Age 7 3.03 (2.92, 3.14)
SDSlope 0.27 (0.26, 0.28)
Correlation (int, slope) 20.86 (20.88, 20.84)
TSH Boys Main effects Age 7 2.32 2.28, 2.36 ,0.001
Slope 0.001 0.0005, 0.002 0.002
Variability SD@ Age 7 0.9 0.87, 0.92
SDSlope 0.01 0.01, 0.01
Correlation (int, slope) 20.46 20.52, 20.39
FT3 Boys Main effects Age 7 6.23 6.2, 6.25 ,0.001
Slope 20.0005 20.001, 0.000009 0.09
Variability SD@ Age 7 0.63 0.61, 0.64
SDSlope 0.009 0.008, 0.009
Correlation (int, slope) 20.58 20.63, 20.53
FT4 Boys Main effects Age 7 15.5 15.4, 15.6 ,0.001
Slope 0.0003 20.001, 0.002 0.72
Variability SD@ Age 7 1.63 1.58, 1.68
SDSlope 0.022 0.021, 0.023
Correlation (int, slope) 20.41 20.48, 20.34
TSH Girls Main effects Age 7 2.21 2.17, 2.24
Slope 0.001 0.0004, 0.002 ,0.001
Variability SD@ Age 7 0.92 0.89, 0.95
SDSlope 0.01 0.01, 0.01
Correlation (int, slope) 20.52 20.58, 20.46
FT3 Girls Main effects Age 7 6.36 6.33, 6.38 ,0.001
Slope 20.009 20.01, 20.08 ,0.001
Variability SD@ Age 7 0.61 0.59, 0.63
SDSlope 0.009 0.008, 0.009
Correlation (int, slope) 20.61 20.66, 20.56
FT4 Girls Main effects Age 7 15.9 15.8, 16 ,0.001
Slope 20.004 20.006, 20.002 ,0.001
Variability SD@ Age 7 1.74 1.69, 1.8
SDSlope 0.022 0.21, 0.22
Correlation (int, slope) 20.42 20.49, 20.35
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available and paired thyroid function at two age points,
which allows more robust analysis than previous studies
of cross-sectional samples. The nature of the cohort
means it is unlikely that interfering medications or het-
erophilic antibodies have influenced results. Further-
more, our use of liner mixed models has allowed us to
determine the change of TSH and thyroid hormone levels
between ages 7 and 15, while simultaneously adjusting
for an individual’s baseline hormone levels, allowing us to
investigate howvariability reduces as children progress into
adulthood. Limitations of our study include a higher social
class bias in our dataset and lack of generalizability to
ethnic minorities, as 98% of all samples analyzed were in
individuals of Caucasian descent. Aweakness is that paired
samples were also not all performed on the same assay run.
Furthermore, all individualswere froma small region of the
UK that has been shown to be borderline iodine deficient
(31). Our findings require replication in individuals from
other ethnic groups and using different thyroid hormone
assays from an area of iodine sufficiency.
In conclusion, our results demonstrate that thyroid
hormone levels change substantially during childhood
and adolescence. This is particularly the case with FT3,
which is substantially higher in younger children. FT3
levels also appear to influence the onset of puberty;
further studies into the pituitary–thyroid axis in normal
childhood populations are therefore needed to define the
role of higher FT3 levels in childhood more precisely.
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